K000664

Substantially Equivalent

VIGILANCE CCO/CEDV & VIGILANCE CCO/SVO2/CEDV MONITORS

Applicant: Baxter Healthcare Corp
Product code: DXG
Advisory panel: Cardiovascular
Date received: 2000-02-28
Decision date: 2000-09-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.